class=" no-sidebar site-layout-full-width is-page footer-no-widget elementor-default elementor-kit-7 elementor-page elementor-page-5273">

Compound Information

Quick Contact

Email Id :

Mobile: 

+91-9666166015

Structure

Product Name

2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-
yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl)-
4,4,dimethyl-4,5-Dihydrooxazole (CAS No. 202189-77-3)

CAS No.

202189-77-3

PropertyDetails
Product Name2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-
yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl)-
4,4,dimethyl-4,5-Dihydrooxazole (CAS No. 202189-77-3)
Structure
CAS No.CAS No. 202189-77-3
Related to PharmaBilastine
Molecular FormulaC32H44N4O2
Formula Weight516.72
Storage ConditionAmbient

Compound Specification

PropertyDetails
DescriptionLight brown to Off white color powder
Identification by HPLCThe retention time of principal peak in the sample
chromatogram should match with that of working
standard chromatogram in the test, Related substance by
HPLC
Chromatographic purity by HPLC
PurityNot less than 99.00%

SDS Information

Product Identification

Chemical Name : 2-(2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2- yl)piperidin-1-
yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl- 4,5-dihydrooxazole

CAS No : 202189-77-3
Molecular Weight : 516.7
Chemical Formula : C32H44N4O2

Composition/Information on Ingredients

IngredientCAS NoClassificationHazardous
2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-
yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl)-
4,4,dimethyl-4,5-Dihydrooxazole (CAS No. 202189-77-3)

202189-77-3

 Nil

Hazards Identification

Emergency Overview
Appearance : White Hygroscopic Solid
Potential Health Effects
Eye : No information found.
Skin : No information found.
Ingestion: No information found.
Inhalation: No information found.
Chronic: No information found.

First Aid Measures Eyes

Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes.

Get medical aid.

Skin: In case of contact, flush skin with plenty of water.
Ingestion: Medical assistance for gastric lavage.
Inhalation: Remove to fresh air, artificial respiration or oxygen if necessary.
Notes to Physician: Bilastine Impurity C can be washed with plenty of water in case of any exposure

Fire Fighting Measures

Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam.

Accidental Release Measures

Personal Precautions : Wear self-contained breathing apparatus, avoid dust formation.
Spills/Leaks: Wash with plenty of water, provide adequate ventilation.

Handling and Storage

Handling: Wear surgical gloves
Storage: No information found.

Exposure Controls/Personal Protection

Eyes: Wear appropriate protective eyeglasses or chemical safety goggles.
Skin : Wear appropriate protective Full sleeves apron
Clothing: Cotton
Respirators: Self-contained breathing apparatus

Physical and Chemical Properties

Appearance : White Hygroscopic Solid
Odor : Odorless
MeltingPoint : NA
pH : Basic
Vapor pressure : NA
Vepor Density : NA
Evaportion Rate : NA
Viscosity : NA
BoilingPoint : NA
DecompositionTemp : NA
AutoignitionTemp. : NA
FlashPoint : NA
NFPARating : NA
Explosion Limits
Lower : NA
Upper : NA
Solubility : Chloroform, Methanol
Specific Gravity/Density : NA

Stability and Reactivity

Chemical Stability: NA
Conditions to Avoid: Direct contract to skin
Hazardous Decomposition Products: NIL
Hazardous Polymerization: NIL

Toxicological Information

Not available.

Ecological Information

Not available.

Disposal Considerations

RCRAP-Series : Can be incinerated

Transport Information

Not available.

Regulatory Information

TSCA : Attached the letter
Health & Safety Reporting List : No data Available
Chemical test Results : Chemical analysis report is attached.

Other Information

The information above is believed to be accurate and represents the best information currently
available to us.